AU2001235363A1 - Mibefradil analogues and their use - Google Patents
Mibefradil analogues and their useInfo
- Publication number
- AU2001235363A1 AU2001235363A1 AU2001235363A AU3536301A AU2001235363A1 AU 2001235363 A1 AU2001235363 A1 AU 2001235363A1 AU 2001235363 A AU2001235363 A AU 2001235363A AU 3536301 A AU3536301 A AU 3536301A AU 2001235363 A1 AU2001235363 A1 AU 2001235363A1
- Authority
- AU
- Australia
- Prior art keywords
- mibefradil
- analogues
- mibefradil analogues
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- HBNPJJILLOYFJU-VMPREFPWSA-N Mibefradil Chemical class C1CC2=CC(F)=CC=C2[C@H](C(C)C)[C@@]1(OC(=O)COC)CCN(C)CCCC1=NC2=CC=CC=C2N1 HBNPJJILLOYFJU-VMPREFPWSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200000293 | 2000-02-25 | ||
DKPA200000293 | 2000-02-25 | ||
US18558300P | 2000-02-28 | 2000-02-28 | |
US60185583 | 2000-02-28 | ||
PCT/DK2001/000128 WO2001062740A1 (en) | 2000-02-25 | 2001-02-23 | Mibefradil analogues and their use |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001235363A1 true AU2001235363A1 (en) | 2001-09-03 |
Family
ID=26068777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001235363A Abandoned AU2001235363A1 (en) | 2000-02-25 | 2001-02-23 | Mibefradil analogues and their use |
Country Status (3)
Country | Link |
---|---|
US (1) | US20010049447A1 (en) |
AU (1) | AU2001235363A1 (en) |
WO (1) | WO2001062740A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1542683B1 (en) * | 2002-09-12 | 2013-01-09 | Diakron Pharmaceuticals, Inc. | Calcium channel blockers |
US20060003985A1 (en) * | 2002-10-17 | 2006-01-05 | Renger John J | Enhancement of sleep with t-type calcium channel antagonists |
EP1730190A4 (en) * | 2004-02-11 | 2008-07-23 | Univ Virginia | INHIBITION OF CAV3 ISOFORMS AND SPLICE VARIANTS $ G (D) 25B FOR CANCER DIAGNOSIS AND TREATMENT |
AU2011203315B8 (en) * | 2004-02-11 | 2012-02-16 | University Of Virginia Patent Foundation | Inhibiting CAV3 isoforms and the delta25B splice varients for the diagnosis and treatment of cancer |
JP4927735B2 (en) * | 2004-08-20 | 2012-05-09 | ユニバーシテイ・オブ・バージニア・パテント・フアウンデーシヨン | T-type calcium channel inhibitor |
CN102781316B (en) | 2010-03-01 | 2016-07-06 | 陶制药有限责任公司 | Cancer diagnosis and imaging |
CN102614172A (en) * | 2012-04-18 | 2012-08-01 | 中国人民解放军第三军医大学第二附属医院 | Application of T-type calcium channel retardant in drug for treating diabetes |
DK3057934T3 (en) * | 2013-10-18 | 2019-07-01 | Blanchette Rockefeller Neurosciences Inst | Halogenated esters of cyclopropanated unsaturated fatty acids for use in the treatment of neurodegenerative diseases |
ES2936400T3 (en) | 2015-10-22 | 2023-03-16 | Cavion Inc | Methods to treat Angelman syndrome |
EP3585376A4 (en) | 2017-02-15 | 2020-11-25 | Cavion, Inc. | Calcium channel inhibitors |
CN110770221B (en) | 2017-04-26 | 2023-09-08 | 卡维昂公司 | Methods for improving memory and cognition and for treating memory and cognition disorders |
US20220016095A1 (en) | 2018-10-03 | 2022-01-20 | Cavion, Inc. | Treating essential tremor using (r)-2-(4-isopropylphenyl)-n-(1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl)acetamide |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK171349B1 (en) * | 1986-11-14 | 1996-09-16 | Hoffmann La Roche | Tetrahydronaphthalane derivatives, process for their preparation, medicaments containing the compounds and use of the compounds for the manufacture of medicaments |
BR9912021A (en) * | 1998-07-10 | 2001-04-03 | Novartis Ag Novartis Sa Movart | Treatment method and pharmaceutical composition |
WO2000015845A1 (en) * | 1998-08-26 | 2000-03-23 | South Alabama Medical Science Foundation | T-type calcium channel |
-
2001
- 2001-02-23 AU AU2001235363A patent/AU2001235363A1/en not_active Abandoned
- 2001-02-23 WO PCT/DK2001/000128 patent/WO2001062740A1/en active Application Filing
- 2001-03-27 US US09/818,398 patent/US20010049447A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20010049447A1 (en) | 2001-12-06 |
WO2001062740A1 (en) | 2001-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001256184A1 (en) | 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases | |
AU2002234643A1 (en) | Amphoteric liposomes and the use thereof | |
AU2002235128A1 (en) | Expression miniarrays and uses thereof | |
AU3620600A (en) | Skin-marking devices and their use | |
AU2001287299A1 (en) | Benzoylpyrazols and their use as herbicides | |
AU2003214945A1 (en) | Multi-function catheter and use thereof | |
AU2001249969A1 (en) | Inha inhibitors and their use as antibacterials | |
AU2001287898A1 (en) | Pyrazolopyridines and pyrazolopyridazines as antidiabetics | |
AU2001291072A1 (en) | Releasable strap | |
AU2001240637A1 (en) | Novel imidazotriazinones and the use thereof | |
AU2002219135A1 (en) | Substituted 2-anilino-benzimidazoles and the use thereof as NHE-inhibitors | |
AU2001277526A1 (en) | Substituted benzo-nitro-heterocycles and use thereof as herbicides | |
AU2001264258A1 (en) | Nonwoven-fabric laminate and use thereof | |
GB0101035D0 (en) | Formulation and use thereof | |
AU2002211717A1 (en) | Stresscopins and their uses | |
AU2001261750A1 (en) | Laminate and its use | |
AU2002210916A1 (en) | Endoscope attachment and endoscope | |
AU2001235363A1 (en) | Mibefradil analogues and their use | |
AU2001292936A1 (en) | Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines | |
AU7458201A (en) | Laminate and use thereof | |
AU2001295185A1 (en) | Multiplexing-interleaving and demultiplexing-deinterleaving | |
AU5464901A (en) | Dichloropyridyl- and dichloroisothiazolyl-thiocarboxamides and their use as microbicides | |
AU2000231564A1 (en) | Phosphororganic compounds and the use thereof | |
AU4432001A (en) | Trityl-type compounds and their use | |
AU2001274309A1 (en) | Phosphoglycan messengers and their medical uses |